About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Bap1em1Test
endonuclease-mediated mutation 1, Joseph R Testa
MGI:5638884
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Bap1em1Test/Bap1em1Test involves: FVB MGI:5689166
ht2
Bap1em1Test/Bap1+ involves: FVB MGI:5689167


Genotype
MGI:5689166
hm1
Allelic
Composition
Bap1em1Test/Bap1em1Test
Genetic
Background
involves: FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bap1em1Test mutation (1 available); any Bap1 mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging




Genotype
MGI:5689167
ht2
Allelic
Composition
Bap1em1Test/Bap1+
Genetic
Background
involves: FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bap1em1Test mutation (1 available); any Bap1 mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• low incidence of colon carcinoma
• moderate incidence of mammary carcinoma
• high incidence of ovarian sex cord stromal tumors, mainly granulosa cell tumors
• heterozygotes show a significantly higher incidence and accelerated onset of asbestos-induced malignant mesothelioma (MM), with abdominal swelling noted as early as 20 wks after the first asbestos injection versus 27 wks in wild-type controls
• ultimately, 90% of asbestos-exposed heterozygotes showed abdominal distention, with ~60% of these containing ascites; almost all showed liver anomalies, pancreatic fibrosis, intestinal adhesions, and thickenings of the peritoneum, mesentery, and diaphragm
• heterozygotes exhibited a median survival of 43 wks after initial asbestos exposure versus 55 wks in wild-type controls; 73% of deaths occurred due to peritoneal MM, relative to only 32% in wild-type controls
• although all asbestos-exposed heterozygotes died from MM and other asbestos-related disease by 57 wks, 20% of wild-type controls remained alive and asymptomatic at this time
• in heterozygotes, asbestos-induced MMs were significantly larger and more aggressive than those in wild-type controls, often invading the pancreas, liver, and/or intestinal smooth muscle; occasional metastasis to the lungs was observed
• Ki-67 staining revealed a higher proliferative index in heterozygous MMs relative to wild-type MMs
• in culture, MM cells derived from asbestos-exposed heterozygotes showed loss of expression of the wild-type Bap1 allele, consistent with loss of heterozygosity
• no spontaneous mesotheliomas were detected in untreated heterozygotes up to 87 wks of age
• low incidence of spindle cell tumor of the skin
• moderate incidence of lung carcinoma
• 1 of 17 heterozygotes developed a spontaneous squamous cell carcinoma (SCC) of mammary origin at 18 months of age
• however, heterozygotes showed no abnormalities of the uvea, skin, mesothelial tissues, or other organs except for the single SCC
• low incidence of malignant mesothelioma

digestive/alimentary system
• low incidence of colon carcinoma

homeostasis/metabolism
• heterozygotes show a significantly higher incidence and accelerated onset of asbestos-induced malignant mesothelioma (MM), with abdominal swelling noted as early as 20 wks after the first asbestos injection versus 27 wks in wild-type controls
• ultimately, 90% of asbestos-exposed heterozygotes showed abdominal distention, with ~60% of these containing ascites; almost all showed liver anomalies, pancreatic fibrosis, intestinal adhesions, and thickenings of the peritoneum, mesentery, and diaphragm
• heterozygotes exhibited a median survival of 43 wks after initial asbestos exposure versus 55 wks in wild-type controls; 73% of deaths occurred due to peritoneal MM, relative to only 32% in wild-type controls
• although all asbestos-exposed heterozygotes died from MM and other asbestos-related disease by 57 wks, 20% of wild-type controls remained alive and asymptomatic at this time
• in heterozygotes, asbestos-induced MMs were significantly larger and more aggressive than those in wild-type controls, often invading the pancreas, liver, and/or intestinal smooth muscle; occasional metastasis to the lungs was observed
• Ki-67 staining revealed a higher proliferative index in heterozygous MMs relative to wild-type MMs
• in culture, MM cells derived from asbestos-exposed heterozygotes showed loss of expression of the wild-type Bap1 allele, consistent with loss of heterozygosity
• no spontaneous mesotheliomas were detected in untreated heterozygotes up to 87 wks of age

endocrine/exocrine glands
• moderate incidence of mammary carcinoma
• high incidence of ovarian sex cord stromal tumors, mainly granulosa cell tumors

integument
• moderate incidence of mammary carcinoma
• low incidence of spindle cell tumor of the skin

cellular
• increased susceptibility to asbestos-induced malignant mesothelioma formation may be facilitated, at least in part, by a Cdkn2a-independent mechanism involving epigenetic dysregulation of Rb1
• malignant mesothelioma (MM) cells derived from heterozygotes exhibit decreased expression of Rb1 due to hypermethylation of the Rb1 promoter

reproductive system
• high incidence of ovarian sex cord stromal tumors, mainly granulosa cell tumors

hematopoietic system
N
• at 3 and 18 months of age, peripheral blood smears and complete blood counts were comparable to those in wild-type controls
• at 18 months of age, bone marrow smears showed no evidence of myelodysplastic syndrome (MDS) or other hematologic disease

respiratory system
• moderate incidence of lung carcinoma





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory